24/11/2025
【 🇯🇵 榮耀時刻！奇翼醫電前進日本 Daicel 總部，深化臺日跨國合作 🇹🇼 】
我們很榮幸與大家分享，奇翼醫電（Singular Wings Medical）作為 「2025 Daicel 企業加速器」年度大獎得主，於本月11日在 工研院產服中心 ITRI 的帶領下，正式前往日本東京 Daicel 集團總部進行技術交流與 PoC 驗證！🚀
在本次行程中，由執行長李維中（David Lee）親自向 Daicel 研發與技術專家團隊，展示我們核心的 「非侵入式人體生理資訊感測技術」。透過 AI /ML人工智慧演算法合先進感測，精準監測連續血糖、心跳等關鍵數據。這項技術不僅獲得現場專家的驚艷與高度評價，更被認為能與 Daicel 在智慧醫療材料應用上創造巨大的綜效！💡
非常感謝 Daicel Group 對我們的肯定，以及工研院 的大力促成，搭建起這座通往國際市場的橋樑。這不僅是奇翼醫電的重要里程碑，更是臺灣新創技術獲得國際百年企業認證的證明。
未來，我們將持續深耕技術、佈局全球，讓臺灣的智慧醫療創新實力在世界舞台發光！🌍✨
👇 了解更多本次交流細節：
https://www.t-hubtaipei.com/news_detail/456
#奇翼醫電 #工研院 #智慧醫療 #新創加速器 #台日合作 #數位健康 #東京 #非侵入式連續血糖偵測 #糖尿病管理
由日本百年企業 Daicel 集團與臺灣工業技術研究院（ITRI）攜手合作的「Daicel 企業加速器」，2025年度大獎得主 --- 奇翼醫電（Singular Wings Medical），於2025年11月11日在工研院產服中心執行長陳立偉博士 (Dr. Lewis Chen)的領軍及見證下，前往 Daicel 集團東京總部進行概念驗證（PoC）與技術交流，為臺日跨國企業與新創合作立下新的里程碑。
企業型加速器 樹立企業與新創生態系的CSE合作典範 實踐工研院「凝聚專才、布局全球」策略
交流活動PoC Pitch一展開，由工研院產業服務中心 Daicel Accelerator Partnership Director 何明豐博士 (Dr. Michael Ho) 於開場時介紹工研院在產業服務與新創鏈結上的角色，並感謝 Daicel 集團對臺灣創新能量的肯定。
何明豐博士強調，連續兩年的 Daicel Accelerator 活動已為臺灣新創圈搭建了開拓日本市場的對接橋樑，是「企業參與新創（Corporate Startups Engagement，CSE）」模式的典範，同時具體落實了工研院「凝聚專才」與「布局全球」兩大經營主軸 。工研院透過廣納院內外頂尖人才，激發跨機構、跨領域協作 ，結合「2035技術策略與藍圖」所聚焦的智慧生活、健康樂活、永續環境、韌性社會等前瞻及關鍵技術 ，加速產業化。
本次計畫即是工研院「布局全球」的重要策略展現 。透過 Daicel Accelerator 計畫，雙方已建立深度合作關係，不僅持續推動創新技術商業化，更成功協助產業拓展全球市場 ，提高臺灣的全球能見度 ，實現雙贏綜效。
此外，工研院產服中心亦負責執行 TTA 臺灣科技新創基地、t.Hub 內科創新育成基地、TAcc+、TREE 等計畫，持續整合新創資源，促進新創與企業鏈結國際市場。本次 Daicel Accelerator 計畫亦成功引介 TTA、TAcc+、TREE 校友及 t.Hub 新創團隊，促進臺灣新創生態系加速前進。
奇翼醫電創新技術獲肯定 助「深耕台灣」鞏固產業競爭力
奇翼醫電 李維中(David Lee) 執行長在 PoC Pitch 中詳細說明創新技術之特徵及優勢，並與 Daicel 研發、業務及技術專家們進行深度交流，展示其核心技術：獨家非接觸式人體生理資訊感測技術。奇翼醫電專注於結合 AI 影像辨識與先進感測技術，開發出可精準、即時監測人體血糖、心跳等生理數據的產品。這項創新與 Daicel 在智慧醫療技術（Smart Medtech）和非接觸式感測人體生理資訊（Non-invasive vital sensing） 的徵案領域高度契合。
現場交流熱烈，多位 Daicel 的研發、業務專家到場深入討論與發問，對於奇翼醫電的技術創新與突破表達驚豔。Daicel 專家們肯定此技術的精準度和即時性，認為能為 Daicel 在材料應用和新事業拓展上帶來具體綜效。此次合作不僅加速技術商業化，更在智慧醫療領域助力鞏固臺灣高科技產業的競爭優勢 ，體現工研院「深耕台灣」、以創新驅動產業轉型的目標 。
臺日兩大研發型企業及法人 高層深化交流 見證新創與企業對話
本次交流特別邀請到工研院產業服務中心執行長陳立偉博士親自領隊前往東京總部並擔任見證人。
交流期間，陳立偉執行長與秉持百年來以研發為企業主軸的 Daicel 集團技術長進行了深入會談。雙方就研發成果的商品化路徑、加速器新創與內部研發的綜效，以及未來產業的新方向進行了深度交流。此次高層對話，聚焦於工研院「深耕台灣」的策略實踐，探討如何透過國際合作，鞏固高科技產業競爭優勢 、並協助產業拓展全球市場；同時也呼應「布局全球」的工研院重點方向。
Daicel 技術長高度肯定工研院在鏈結新創與國際企業中的關鍵角色，並承諾未來將與工研院及臺灣新創生態系進行更緊密的交流與長期合作，共同探索創新材料與智慧科技在各應用領域的巨大潛力。
開放式創新模式 引領企業與新創合作新契機 助力台灣產品行銷全世界
Daicel 集團強調，企業加速器是推動開放式創新的關鍵模式，未來將持續邀請全球新創參與，擴大產業合作機會。
工研院產服中心亦將持續扮演臺灣新創生態系的推動者，透過企業型加速器計畫，協助臺灣新創與國際企業合作，助力台灣產品行銷全世界 ，並在國際舞臺上提高臺灣的全球能見度 。
2026 年「DAICEL 企業加速器」計畫即將啟動，誠摯邀請更多新創團隊參與，共創價值！
The winner of the "Daicel Corporate Accelerator," a collaborative initiative between the century-old Japanese corporation Daicel Group and Taiwan's Industrial Technology Research Institute (ITRI), Singular Wings Medical (SWM), journeyed to the Daicel Group's Tokyo Headquarters on November 11, 2025. The visit, led and witnessed by Dr. Lewis Chen, General Director of ITRI's Commercialization and Industry Service Center (CIS), involved a Proof of Concept (PoC) and technical exchange, setting a new milestone for cross-border corporate and startup collaboration between Taiwan and Japan.
Corporate Accelerator Sets CSE Collaboration Benchmark, Fulfilling ITRI's Strategy of "Integrating Expertise and Global Deployment"
The PoC Pitch session commenced with Dr. Michael Ho, Partnership Director of Daicel-ITRI Accelerator, introducing ITRI's role in industrial services and startup linkage. He expressed gratitude for the Daicel Group's affirmation of Taiwan's innovation power.
Dr. Ho emphasized that the two consecutive years of the Daicel Accelerator program have built a bridge for Taiwanese startups to open up international markets, serving as a model for Corporate Startups Engagement (CSE). Furthermore, this initiative specifically embodies ITRI's two major operational priorities: "Integrating Expertise" and "Global Deployment."
ITRI accelerates industrialization by recruiting top talent both internally and externally, fostering cross-institutional and cross-disciplinary collaboration. This is done in alignment with the "2035 Technology Strategy and Roadmap," which focuses on Smart Living, Quality Health, Sustainable Environment, and Resilient Society as key forward-looking technologies.
This project is a vital expression of ITRI's "Global Deployment" strategy. Through the Daicel Accelerator, both parties have established a deep cooperative relationship that not only continually promotes the commercialization of innovative technologies but also successfully assists the industry in expanding global markets, enhancing Taiwan's global visibility, and achieving win-win synergy.
In addition, ITRI's CIS executes key programs such as TTA (Taiwan Tech Arena), t.Hub, TAcc+, and TREE, continuously integrating startup resources to connect startups with international markets. The Daicel Accelerator program successfully introduced alumni and teams from TTA, TAcc+, TREE, and t.Hub, accelerating the progress of the Taiwanese startup ecosystem.
Singular Wings Medical's Innovation Recognized, Aiding "Deeply Rooted in Taiwan" Strategy to Solidify Industrial Competitiveness
David Lee, CEO of Singular Wings Medical, detailed the features and advantages of his innovative technology during the PoC Pitch. He engaged in deep exchange with Daicel R&D, business, and technical experts, showcasing the core technology: Exclusive Non-invasive Vital Sensing Technology. SWM focuses on combining AI image recognition with advanced sensing technology to develop products that can accurately and instantly monitor human physiological data, such as blood sugar and heart rate. This innovation highly aligns with Daicel's solicitation areas, including Smart Medtech and Non-invasive vital sensing.
The exchange was lively, with multiple Daicel R&D and business experts participating in in-depth discussions, expressing admiration for SWM's technical innovation and breakthroughs. Daicel experts affirmed the technology's precision and real-time capability, believing it will bring substantial synergy to Daicel's material applications and new business development. This collaboration not only speeds up technology commercialization but also helps solidify Taiwan's high-tech industry competitive advantage in the smart medical field, reflecting ITRI's goal of "Deeply Rooted in Taiwan" by driving industrial transformation through innovation.
High-Level Dialogue Between Two Major R&D Corporations/Institutions Witnesses Startup-Corporate Exchange
The exchange was specially led and witnessed by Dr. Lewis Chen, General Director of ITRI's Commercialization and Industry Service Center.
During the exchange, Dr. Lewis Chen held an in-depth meeting with the Chief Technology Officer of the Daicel Group, a company built on a century of R&D focus. Both parties engaged in deep communication regarding the commercialization pathway of R&D outcomes, the synergy between accelerator startups and internal R&D, and future industry directions. This high-level dialogue focused on the strategic ex*****on of ITRI's "Deeply Rooted in Taiwan" principle, exploring how international cooperation can consolidate high-tech industrial competitive advantages and assist industries in expanding global markets, while also echoing the "Global Deployment" corporate direction.
The Daicel CTO highly affirmed ITRI's crucial role in connecting startups with international corporations and committed to establishing closer communication and long-term cooperation with ITRI and the Taiwanese startup ecosystem, jointly exploring the immense potential of innovative materials and smart technology across various application fields.
Open Innovation Model Leads to New Corporate-Startup Cooperation Opportunities, Boosting Global Marketing for Taiwanese Products
The Daicel Group emphasized that the Corporate Accelerator is a key model for promoting Open Innovation and will continue to invite global startups to participate in the future, expanding opportunities for industrial cooperation.
ITRI's CIS will continue to act as a catalyst for the Taiwanese startup ecosystem. Through the corporate accelerator program, it will assist Taiwanese startups in cooperating with international enterprises, helping Taiwanese products market worldwide, and enhancing Taiwan's global visibility on the international stage.
The "2026 DAICEL Corporate Accelerator" program is set to launch soon, and we sincerely invite more startup teams to participate and co-create value!
